James Miles, The Economist's China writer at large, shares insights into the contrasting views in China regarding the upcoming U.S. elections, discussing why some may prefer Trump over Biden. Meanwhile, Rachel Dobbs, News editor at The Economist, delves into groundbreaking advancements in endometriosis treatment, revealing promising new non-hormonal options. The conversation also humorously reflects on two decades of podcasting, touching on its evolution, challenges, and the unique storytelling that captivates listeners.
Ordinary Chinese citizens view Trump favorably for benefiting China's image, while government fears trade conflicts. Joe Biden's tough stance raises concerns about tariffs and tech exports.
Endometriosis drug trial at University of Edinburgh shows promise with dipteroacetate, a breakthrough in treating the debilitating disease.
Deep dives
China's Views on US Presidential Candidates
Ordinary Chinese citizens view Donald Trump favorably due to perceptions of him being good for China's image and undermining democracy. On the other hand, concerns exist within the Chinese government regarding potential trade conflicts and economic impacts. In contrast, Joe Biden is perceived as tougher on China, maintaining tariffs and limiting tech exports, causing apprehension in China's leadership.
Progress in Endometriosis Research
Endometriosis is a chronic condition predominantly affecting women, with diagnosis challenges and limited treatment options. Recent advancements at the University of Edinburgh offer hope through a drug trial showing promising results. The study focused on lactate levels in endometriosis patients, linking to a potential new treatment, dipteroacetate, signaling a significant breakthrough.
Evolution and Challenges in Podcasting
The podcasting medium has experienced growth and challenges with notable shows like 'Serial' driving its popularity. Despite initial success, the industry faced setbacks with unreliable metrics and financial cutbacks, prompting a reevaluation. The future of podcasting may involve diversification, such as focusing on video content and exploring new formats to adapt to changing audience preferences.
Some within China might prefer another Donald Trump presidency while others might favour Joe Biden. On balance, though: from there, neither option looks great. We look at the steps toward the first drug in four decades to treat the debilitating disease of endometriosis (9:28). And as the word podcasting turns 20 we reflect on a medium close to our hearts (17:51).
If you’re already a subscriber to The Economist, you’ll have full access to all our shows as part of your subscription. For more information about how to access Economist Podcasts+, please visit our FAQs page or watch our video explaining how to link your account.
Get the Snipd podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered podcast player
Listen to all your favourite podcasts with AI-powered features
Discover highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share & Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered podcast player
Listen to all your favourite podcasts with AI-powered features
Discover highlights
Listen to the best highlights from the podcasts you love and dive into the full episode